Wellgistics Health Inc. Financials
This page shows Wellgistics Health Inc. (WGRX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A thin-margin operating model became a balance-sheet-funded cost surge as expenses outran a still-small revenue base.
From FY2024 to FY2025, revenue reached only$23.3M while SG&A expanded to$70.3M , so the cost structure scaled far faster than the sales engine. Because gross margin turned negative but operating cash burn was$10.9M against a net loss of$101.3M , the reported collapse includes a large accrual or non-cash component rather than equal cash draining out.
With just
After the FY2024 asset build, total assets fell to
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Wellgistics Health Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Wellgistics Health Inc. has an operating margin of -401.7%, meaning the company retains $-402 of operating profit per $100 of revenue. This below-average margin results in a low score of 16/100, suggesting thin profitability after operating expenses. This is down from -33.9% the prior year.
Wellgistics Health Inc.'s revenue surged 28.7% year-over-year to $23.3M, reflecting rapid business expansion. This strong growth earns a score of 88/100.
Wellgistics Health Inc.'s current ratio of 0.09 is below the typical benchmark, resulting in a score of 1/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Wellgistics Health Inc. scores -15.43, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($8.8M) relative to total liabilities ($42.9M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Wellgistics Health Inc. passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Wellgistics Health Inc. generates $0.11 in operating cash flow (-$10.9M OCF vs -$101.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Wellgistics Health Inc. earns $-20.5 in operating income for every $1 of interest expense (-$93.7M vs $4.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
Wellgistics Health Inc. generated $23.3M in revenue in fiscal year 2025. This represents an increase of 28.7% from the prior year.
Wellgistics Health Inc.'s EBITDA was -$90.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1699.8% from the prior year.
Wellgistics Health Inc. reported -$101.3M in net income in fiscal year 2025. This represents a decrease of 1377.1% from the prior year.
Wellgistics Health Inc. earned $-1.43 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 853.3% from the prior year.
Cash & Balance Sheet
Wellgistics Health Inc. held $43K in cash against $12.6M in long-term debt as of fiscal year 2025.
Wellgistics Health Inc. had 90M shares outstanding in fiscal year 2025. This represents an increase of 75.7% from the prior year.
Margins & Returns
Wellgistics Health Inc.'s gross margin was -27.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 37.3 percentage points from the prior year.
Wellgistics Health Inc.'s operating margin was -401.7% in fiscal year 2025, reflecting core business profitability. This is down 367.8 percentage points from the prior year.
Wellgistics Health Inc.'s net profit margin was -433.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 396.1 percentage points from the prior year.
Capital Allocation
WGRX Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6M-6.6% | $1.7M-44.6% | $3.0M-61.3% | $7.8M-28.3% | $10.9M | N/A | $5.7M+12638.8% | $45K |
| Cost of Revenue | $1.4M-85.4% | $9.5M+242.4% | $2.8M-61.8% | $7.3M-28.4% | $10.2M | N/A | $5.2M+10828.6% | $47K |
| Gross Profit | $170K+102.2% | -$7.9M-3500.6% | $231K-54.3% | $506K-27.0% | $693K | N/A | $521K+20086.3% | -$3K |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $4.9M+18.0% | $4.1M-86.3% | $30.2M+520.8% | $4.9M-84.4% | $31.2M | N/A | $1.8M+215.3% | $570K |
| Operating Income | -$6.0M+76.3% | -$25.4M+19.6% | -$31.5M-473.6% | -$5.5M+82.5% | -$31.3M | N/A | -$1.7M-204.5% | -$573K |
| Interest Expense | $2.1M+136.7% | $876K-38.6% | $1.4M+20.4% | $1.2M+8.2% | $1.1M | N/A | $138K+10412.9% | $1K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$7.7M+72.2% | -$27.9M+18.8% | -$34.3M-414.3% | -$6.7M+79.4% | -$32.4M | N/A | -$1.9M-225.1% | -$574K |
| EPS (Diluted) | $-0.07 | N/A | $-0.46-318.2% | $-0.11+82.3% | $-0.62 | N/A | $-0.04-300.0% | $-0.01 |
WGRX Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.1M-1.1% | $30.5M-42.3% | $52.8M-2.7% | $54.2M-6.6% | $58.1M+1.3% | $57.3M | N/A | N/A |
| Current Assets | $2.8M-2.0% | $2.8M-78.0% | $12.8M-5.1% | $13.5M-18.4% | $16.6M+9.1% | $15.2M | N/A | N/A |
| Cash & Equivalents | $52K+21.5% | $43K-99.0% | $4.2M+907.0% | $420K-83.3% | $2.5M+144.7% | $1.0M | N/A | N/A |
| Inventory | $1.7M+4.5% | $1.6M-78.1% | $7.5M-17.0% | $9.0M-7.2% | $9.7M+2.3% | $9.5M | N/A | N/A |
| Accounts Receivable | $992K-12.8% | $1.1M+3.4% | $1.1M-49.1% | $2.2M-23.6% | $2.8M+3.8% | $2.7M | N/A | N/A |
| Goodwill | $14.2M0.0% | $14.2M-12.5% | $16.2M0.0% | $16.2M0.0% | $16.2M0.0% | $16.2M | N/A | N/A |
| Total Liabilities | $45.2M+5.3% | $42.9M-6.7% | $46.0M-13.7% | $53.3M-0.5% | $53.6M+5.9% | $50.6M | N/A | N/A |
| Current Liabilities | $32.2M+8.1% | $29.8M-9.0% | $32.7M-22.8% | $42.4M-8.3% | $46.2M+21.5% | $38.0M | N/A | N/A |
| Long-Term Debt | $12.6M0.0% | $12.6M0.0% | $12.6M+24.8% | $10.1M-58.1% | $24.1M+110.6% | $11.5M | N/A | N/A |
| Total Equity | -$15.1M-21.0% | -$12.4M-283.6% | $6.8M+648.7% | $905K-79.8% | $4.5M-33.5% | $6.7M-32.6% | $10.0M+417.2% | -$3.1M |
| Retained Earnings | -$118.8M-7.0% | -$111.0M-33.5% | -$83.2M-70.2% | -$48.9M-15.8% | -$42.2M-332.4% | -$9.8M | N/A | N/A |
WGRX Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$3.4M+45.8% | -$6.3M-454.3% | -$1.1M+45.4% | -$2.1M-54.3% | -$1.3M+48.6% | -$2.6M-352.9% | $1.0M+214.5% | $330K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$205K+19.7% | -$255K-15.5% | -$221K-67.6% | -$132K+51.7% | -$273K-134.0% | $803K+354.0% | -$316K | N/A |
| Financing Cash Flow | $3.6M+53.5% | $2.4M-54.3% | $5.2M+4419.7% | $114K-96.3% | $3.1M+51.2% | $2.1M+45405.9% | $5K+100.8% | -$538K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
WGRX Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.9%+481.1pp | -470.2%-477.9pp | 7.7%+1.2pp | 6.5%+0.1pp | 6.4% | N/A | 9.2%+15.0pp | -5.9% |
| Operating Margin | -385.7%+1131.8pp | -1517.5%-470.4pp | -1047.1%-976.5pp | -70.6%+218.0pp | -288.6% | N/A | -30.8%+1255.8pp | -1286.5% |
| Net Margin | -496.5%+1170.7pp | -1667.2%-528.2pp | -1139.0%-1053.4pp | -85.6%+212.9pp | -298.5% | N/A | -32.9%+1256.5pp | -1289.5% |
| Return on Equity | N/A | N/A | -506.3%+230.8pp | -737.1%-13.0pp | -724.1% | N/A | -18.7% | N/A |
| Return on Assets | -25.7%+65.7pp | -91.4%-26.4pp | -65.0%-52.7pp | -12.3%+43.5pp | -55.9% | N/A | N/A | N/A |
| Current Ratio | 0.090.0 | 0.09-0.3 | 0.39+0.1 | 0.32-0.0 | 0.36-0.0 | 0.40 | N/A | N/A |
| Debt-to-Equity | N/A | N/A | 1.86-9.3 | 11.16+5.8 | 5.39+3.7 | 1.70 | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$12.4M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.09), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Wellgistics Health Inc.'s annual revenue?
Wellgistics Health Inc. (WGRX) reported $23.3M in total revenue for fiscal year 2025. This represents a 28.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Wellgistics Health Inc.'s revenue growing?
Wellgistics Health Inc. (WGRX) revenue grew by 28.7% year-over-year, from $18.1M to $23.3M in fiscal year 2025.
Is Wellgistics Health Inc. profitable?
No, Wellgistics Health Inc. (WGRX) reported a net income of -$101.3M in fiscal year 2025, with a net profit margin of -433.9%.
What is Wellgistics Health Inc.'s EBITDA?
Wellgistics Health Inc. (WGRX) had EBITDA of -$90.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Wellgistics Health Inc. have?
As of fiscal year 2025, Wellgistics Health Inc. (WGRX) had $43K in cash and equivalents against $12.6M in long-term debt.
What is Wellgistics Health Inc.'s gross margin?
Wellgistics Health Inc. (WGRX) had a gross margin of -27.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Wellgistics Health Inc.'s operating margin?
Wellgistics Health Inc. (WGRX) had an operating margin of -401.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Wellgistics Health Inc.'s net profit margin?
Wellgistics Health Inc. (WGRX) had a net profit margin of -433.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Wellgistics Health Inc.'s operating cash flow?
Wellgistics Health Inc. (WGRX) generated -$10.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Wellgistics Health Inc.'s total assets?
Wellgistics Health Inc. (WGRX) had $30.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Wellgistics Health Inc.'s current ratio?
Wellgistics Health Inc. (WGRX) had a current ratio of 0.09 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Wellgistics Health Inc.'s return on assets (ROA)?
Wellgistics Health Inc. (WGRX) had a return on assets of -332.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Wellgistics Health Inc.'s cash runway?
Based on fiscal year 2025 data, Wellgistics Health Inc. (WGRX) had $43K in cash against an annual operating cash burn of $10.9M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Wellgistics Health Inc.'s debt-to-equity ratio negative or not reported?
Wellgistics Health Inc. (WGRX) has negative shareholder equity of -$12.4M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Wellgistics Health Inc.'s Altman Z-Score?
Wellgistics Health Inc. (WGRX) has an Altman Z-Score of -15.43, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Wellgistics Health Inc.'s Piotroski F-Score?
Wellgistics Health Inc. (WGRX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Wellgistics Health Inc.'s earnings high quality?
Wellgistics Health Inc. (WGRX) has an earnings quality ratio of 0.11x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Wellgistics Health Inc. cover its interest payments?
Wellgistics Health Inc. (WGRX) has an interest coverage ratio of -20.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Wellgistics Health Inc.?
Wellgistics Health Inc. (WGRX) scores 25 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.